TARA Biosystems Overview
- Year Founded
-
2014
- Status
-
Acquired/Merged
- Employees
-
30
- Latest Deal Type
-
M&A
- Investors
-
1
TARA Biosystems General Information
Description
Operator of a biotech and an early-stage life-science technology company intended to harness human biology and data to transform cardiac drug discovery by using predictive cardiac tissue models. The company specializes in using stem cells to produce heart cells so that changes in human cardiac function can be measured without human testing, allowing physicians to address heart issues to improve the health and life of their patients.
Contact Information
Website
www.tarabiosystems.comCorporate Office
- 430 East 29th Street
- Suite 1015
- New York, NY 10016
- United States
Corporate Office
- 430 East 29th Street
- Suite 1015
- New York, NY 10016
- United States
TARA Biosystems Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Merger/Acquisition | 01-Apr-2022 | Completed | Generating Revenue | |||
| 9. Later Stage VC | 17-Nov-2021 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series A2) | 23-Jun-2020 | Completed | Generating Revenue | |||
| 7. Debt - PPP | 11-Apr-2020 | Completed | Generating Revenue | |||
| 6. Early Stage VC (Series A) | 24-Jan-2018 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 18-Apr-2017 | Completed | Startup | |||
| 4. Seed Round | 15-Dec-2015 | Completed | Startup | |||
| 3. Accelerator/Incubator | 01-Jan-2015 | Completed | Startup | |||
| 2. Seed Round | 12-Nov-2014 | $300K | $300K | Completed | Startup | |
| 1. University Spin-Out | 01-Jan-2014 | Completed | Startup |
TARA Biosystems Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A2 | ||||||||
| Series A |
TARA Biosystems Comparisons
Industry
Financing
Details
TARA Biosystems Competitors (24)
One of TARA Biosystems’s 24 competitors is Ncardia, a Venture Capital-Backed company based in Leiden, Netherlands.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ncardia | Venture Capital-Backed | Leiden, Netherlands | ||||
| Nagi Bioscience | Venture Capital-Backed | Saint-Sulpice, Switzerland | ||||
| MIMETAS | Venture Capital-Backed | Oegstgeest, Netherlands | ||||
| Humacyte | Formerly VC-backed | Durham, NC | ||||
| Orgenesis | Corporation | Germantown, MD |
TARA Biosystems Patents
TARA Biosystems Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2021158233-A1 | A microphysiological platform with embedded electrodes for 3d tissue culture | Inactive | 07-Feb-2020 | ||
| US-12595449-B2 | Integrated system for 3d tissue culture | Active | 07-Feb-2020 | ||
| US-20230113389-A1 | Integrated system for 3d tissue culture | Active | 07-Feb-2020 | ||
| WO-2021158598-A1 | Integrated system for 3d tissue culture | Inactive | 07-Feb-2020 | ||
| CA-2965143-A1 | Microfabricated tissue scaffolds and methods of making and using the same | Inactive | 20-Oct-2014 | A61L27/3826 |
TARA Biosystems Signals
TARA Biosystems Former Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 180 Degree Capital | Hedge Fund | Minority | ||
| Alexandria Venture Investments | Venture Capital | Minority | ||
| DEFTA Partners | Venture Capital | Minority | ||
| Empire State Development | Government | Minority | ||
| Lifeforce Capital | Venture Capital | Minority |
TARA Biosystems FAQs
-
When was TARA Biosystems founded?
TARA Biosystems was founded in 2014.
-
Where is TARA Biosystems headquartered?
TARA Biosystems is headquartered in New York, NY.
-
What is the size of TARA Biosystems?
TARA Biosystems has 30 total employees.
-
What industry is TARA Biosystems in?
TARA Biosystems’s primary industry is Drug Discovery.
-
Is TARA Biosystems a private or public company?
TARA Biosystems is a Private company.
-
What is TARA Biosystems’s current revenue?
The current revenue for TARA Biosystems is .
-
How much funding has TARA Biosystems raised over time?
TARA Biosystems has raised $29.2M.
-
Who are TARA Biosystems’s investors?
180 Degree Capital, Alexandria Venture Investments, DEFTA Partners, Empire State Development, and Lifeforce Capital are 5 of 14 investors who have invested in TARA Biosystems.
-
Who are TARA Biosystems’s competitors?
Ncardia, Nagi Bioscience, MIMETAS, Humacyte, and Orgenesis are some of the 24 competitors of TARA Biosystems.
-
When was TARA Biosystems acquired?
TARA Biosystems was acquired on 01-Apr-2022.
-
Who acquired TARA Biosystems?
TARA Biosystems was acquired by Valo.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process